Latest Oncology Stories
CALGARY, April 20, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
GUILDFORD, England, April 20, 2015 /PRNewswire/ -- ANGLE plc (AIM:AGL OTCQX:ANPCY), the specialist medtech company, is pleased to announce that the Sidney Kimmel Cancer Center at Thomas Jefferson
WASHINGTON, April 20, 2015 /PRNewswire/ -- The Mesothelioma Victims Center is expanding their initiative for diagnosed victims who were exposed to asbestos at an auto or truck manufacturing facility,
$25,000 Awarded to Nikolaus Schultz, PhD for Work on cBioPortal SANTA MONICA, Calif., April 20, 2015 /PRNewswire-USNewswire/ -- The
OXFORD, England, April 20, 2015 /PRNewswire/ -- IMCgp100 shows partial and complete durable responses in Phase I/IIa trial in
Collaboration to provide expanded use of Paradigm Cancer Diagnostic (PCDx(TM)) service by oncologists across large oncology network SCOTTSDALE, Ariz.
Pembrolizumab Demonstrated 28 Percent Overall Response Rate and 76 Percent Disease Control Rate in Difficult-to-Treat Cancer First Findings from KEYNOTE-028, Merck's Innovative
KIRKLAND, QC, April 19, 2015 /CNW Telbec/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from KEYNOTE-001, a Phase 1b study evaluating pembrolizumab,
Rosetta Radiology adds PET-CT to their list of services, providing patients in the Upper East Side with comprehensive, affordable care. New York, NY (PRWEB)
Ubiquitin system produces a protein that greatly restricts the development of cancerous tumors NEW YORK, April 17, 2015 /PRNewswire-USNewswire/ -- Dr.